| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |